Form 8-K MAIA Biotechnology, Inc. For: Nov 10
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/30/2026
- Wall St set for strongest quarter in years as risk appetite holds despite US-Iran war
- Dollar pushes higher, yen sinks to 40-year low
- NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
- Citi says bearish flows are building in Nasdaq and S&P 500
- Patrick and LCI Industries to merge in all-stock deal
- Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
- EchoStar Prepares Dish DBS Bankruptcy Filing as Soon as Tuesday - WSJ
- Strategy stock jumps 7% as firm shifts to active capital management
- New leader board: Citi refreshes AI compute semiconductor picks
- Honeywell completes aerospace spin-off, splits into 3 companies
MAIA Biotechnology (MAIA) Suspends Common Stosk Sales
November 15, 2023 8:49 AM ESTOn November 15, 2023, MAIA Biotechnology (NYSE: MAIA) suspended sales of its common stock, par value $0.0001 per share (Common Stock), pursuant to that certain Sales Agreement, dated as of September 1, 2023 (the Sales Agreement), between the Company and ThinkEquity LLC (the Agent), the Companys sales agent thereunder, and... More
